Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Rizzo currently holds 215,415 shares of Xtant Medical Holdings, Inc. (XTNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Rizzo has been a net buyer of XTNT stock. They have purchased $6.8M and sold $0 worth of shares.
Matthew Rizzo's most recent insider trade was on Aug 15, 2022, when they sold 215,415 shares at $0.00 per share.
Matthew Rizzo serves as Executive at Xtant Medical Holdings, Inc. (XTNT). They have executed 16 insider transactions totaling $6.8M over their tenure at the company.
Matthew Rizzo holds the position of Executive at Xtant Medical Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Matthew Rizzo has shown a buying trading pattern, with $6.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew Rizzo was on Oct 1, 2020, when they purchased $50.1M worth of XTNT shares. This transaction involved 46,784,775 shares at $1.07 per share.
Matthew Rizzo currently owns 215,415 shares of Xtant Medical Holdings, Inc. (XTNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Rizzo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Rizzo has 16 Form 4 filings on record as an insider at Xtant Medical Holdings, Inc..
Set alerts for Matthew Rizzo and 40,000+ other insiders.